Position in NAUT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$239,791
-$163,540 QoQ
Shares Held
61,802
-70.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Derivatives in NAUT
reported options exposure · as of Sep 30, 2021CallValue
$92,100
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in NAUT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $239,791 | 61,802 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $403,331 | 206,837 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $125,217 | 148,188 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $210,516 | 290,369 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $61,868 | 71,857 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $182,355 | 108,545 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $107,392 | 37,682 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $146,721 | 62,702 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $90,419 | 30,755 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $157,537 | 52,688 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $40,757 | 12,898 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $90,020 | 23,261 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $92,656 | 33,450 | Shares | Defined | 2023-05-16 | |
| 2022-06-30 | $33,514 | 12,459 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $125,421 | 28,899 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $64,454 | 12,443 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $92,100 | 15,000 | Call | Defined | 2021-11-16 | |
| 2021-09-30 | $79,568 | 12,959 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $1,754,390 | 173,702 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ARYA | — | 192,419 | Shares | Defined | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||